The 22q11.2 deletion syndrome

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

The 22q11.2 deletion syndrome (22q11DS) encompasses DiGeorge syndrome, velo-cardiofacial syndrome and conotruncal anomaly face syndrome and is due to a microdeletion of chromosome 22q11.2. This is the most frequent known interstitial deletion found in human with an incidence of 1 in 4,000 live births. A large number of clinical findings have been reported in affected patients, including cardiac defects, characteristic facial features, thymic hypoplasia, cleft palate, hypoparathyroidism, learning difficulties and psychiatric disorders. A comprehensive evaluation and follow-up program is necessary for patients with 22q11DS. A striking aspect of the 22q11DS phenotype is its variability, the basis of which remains unclear, and no phenotype-genotype correlation has been made. The structures primarily affected in patients with 22q11DS are derivatives of the embryonic pharyngeal arches and pouches suggesting that haploinsufficiency of the gene(s) on the deleted region, spanning 2-3 Mb, is important in pharyngeal arch/pouch development. Extensive gene searches have been successful in identifying more than 30 genes in the deleted segment. Although standard positional cloning has failed to demonstrate a role for any of these genes in the syndrome, the use of experimental animal models and advanced genome manipulation technologies in mice have been providing an insight into the developmental role of some of these genes, including TBX1. In this review, the clinical features and management of patients with 22q11DS are integrated with our current understanding of the embryological and molecular basis of this syndrome, as presented at the 1235th Meeting of The Keio Medical Society.

Original languageEnglish
Pages (from-to)77-88
Number of pages12
JournalKeio Journal of Medicine
Volume51
Issue number2
Publication statusPublished - 2002 Mar

Fingerprint

DiGeorge Syndrome
Branchial Region
Genes
Haploinsufficiency
Hypoparathyroidism
Medical Societies
Live Birth
Genetic Association Studies
Cleft Palate
Psychiatry
Organism Cloning
Animal Models
Chromosomes
Learning
Genome
Technology
Phenotype
Incidence

Keywords

  • Chromosomal deletion
  • Congenital heart disease
  • Hypocalcemia
  • Pharyngeal arch development
  • Velopharyngeal dysfunction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The 22q11.2 deletion syndrome. / Yamagishi, Hiroyuki.

In: Keio Journal of Medicine, Vol. 51, No. 2, 03.2002, p. 77-88.

Research output: Contribution to journalArticle

@article{6cfbc84d9ad941bd94229291d8fd3520,
title = "The 22q11.2 deletion syndrome",
abstract = "The 22q11.2 deletion syndrome (22q11DS) encompasses DiGeorge syndrome, velo-cardiofacial syndrome and conotruncal anomaly face syndrome and is due to a microdeletion of chromosome 22q11.2. This is the most frequent known interstitial deletion found in human with an incidence of 1 in 4,000 live births. A large number of clinical findings have been reported in affected patients, including cardiac defects, characteristic facial features, thymic hypoplasia, cleft palate, hypoparathyroidism, learning difficulties and psychiatric disorders. A comprehensive evaluation and follow-up program is necessary for patients with 22q11DS. A striking aspect of the 22q11DS phenotype is its variability, the basis of which remains unclear, and no phenotype-genotype correlation has been made. The structures primarily affected in patients with 22q11DS are derivatives of the embryonic pharyngeal arches and pouches suggesting that haploinsufficiency of the gene(s) on the deleted region, spanning 2-3 Mb, is important in pharyngeal arch/pouch development. Extensive gene searches have been successful in identifying more than 30 genes in the deleted segment. Although standard positional cloning has failed to demonstrate a role for any of these genes in the syndrome, the use of experimental animal models and advanced genome manipulation technologies in mice have been providing an insight into the developmental role of some of these genes, including TBX1. In this review, the clinical features and management of patients with 22q11DS are integrated with our current understanding of the embryological and molecular basis of this syndrome, as presented at the 1235th Meeting of The Keio Medical Society.",
keywords = "Chromosomal deletion, Congenital heart disease, Hypocalcemia, Pharyngeal arch development, Velopharyngeal dysfunction",
author = "Hiroyuki Yamagishi",
year = "2002",
month = "3",
language = "English",
volume = "51",
pages = "77--88",
journal = "Keio Journal of Medicine",
issn = "0022-9717",
publisher = "Keio University School of Medicine",
number = "2",

}

TY - JOUR

T1 - The 22q11.2 deletion syndrome

AU - Yamagishi, Hiroyuki

PY - 2002/3

Y1 - 2002/3

N2 - The 22q11.2 deletion syndrome (22q11DS) encompasses DiGeorge syndrome, velo-cardiofacial syndrome and conotruncal anomaly face syndrome and is due to a microdeletion of chromosome 22q11.2. This is the most frequent known interstitial deletion found in human with an incidence of 1 in 4,000 live births. A large number of clinical findings have been reported in affected patients, including cardiac defects, characteristic facial features, thymic hypoplasia, cleft palate, hypoparathyroidism, learning difficulties and psychiatric disorders. A comprehensive evaluation and follow-up program is necessary for patients with 22q11DS. A striking aspect of the 22q11DS phenotype is its variability, the basis of which remains unclear, and no phenotype-genotype correlation has been made. The structures primarily affected in patients with 22q11DS are derivatives of the embryonic pharyngeal arches and pouches suggesting that haploinsufficiency of the gene(s) on the deleted region, spanning 2-3 Mb, is important in pharyngeal arch/pouch development. Extensive gene searches have been successful in identifying more than 30 genes in the deleted segment. Although standard positional cloning has failed to demonstrate a role for any of these genes in the syndrome, the use of experimental animal models and advanced genome manipulation technologies in mice have been providing an insight into the developmental role of some of these genes, including TBX1. In this review, the clinical features and management of patients with 22q11DS are integrated with our current understanding of the embryological and molecular basis of this syndrome, as presented at the 1235th Meeting of The Keio Medical Society.

AB - The 22q11.2 deletion syndrome (22q11DS) encompasses DiGeorge syndrome, velo-cardiofacial syndrome and conotruncal anomaly face syndrome and is due to a microdeletion of chromosome 22q11.2. This is the most frequent known interstitial deletion found in human with an incidence of 1 in 4,000 live births. A large number of clinical findings have been reported in affected patients, including cardiac defects, characteristic facial features, thymic hypoplasia, cleft palate, hypoparathyroidism, learning difficulties and psychiatric disorders. A comprehensive evaluation and follow-up program is necessary for patients with 22q11DS. A striking aspect of the 22q11DS phenotype is its variability, the basis of which remains unclear, and no phenotype-genotype correlation has been made. The structures primarily affected in patients with 22q11DS are derivatives of the embryonic pharyngeal arches and pouches suggesting that haploinsufficiency of the gene(s) on the deleted region, spanning 2-3 Mb, is important in pharyngeal arch/pouch development. Extensive gene searches have been successful in identifying more than 30 genes in the deleted segment. Although standard positional cloning has failed to demonstrate a role for any of these genes in the syndrome, the use of experimental animal models and advanced genome manipulation technologies in mice have been providing an insight into the developmental role of some of these genes, including TBX1. In this review, the clinical features and management of patients with 22q11DS are integrated with our current understanding of the embryological and molecular basis of this syndrome, as presented at the 1235th Meeting of The Keio Medical Society.

KW - Chromosomal deletion

KW - Congenital heart disease

KW - Hypocalcemia

KW - Pharyngeal arch development

KW - Velopharyngeal dysfunction

UR - http://www.scopus.com/inward/record.url?scp=0036596250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036596250&partnerID=8YFLogxK

M3 - Article

C2 - 12125909

AN - SCOPUS:0036596250

VL - 51

SP - 77

EP - 88

JO - Keio Journal of Medicine

JF - Keio Journal of Medicine

SN - 0022-9717

IS - 2

ER -